Evrolia

Everolimus

Category:

Chemical

Chemical

Oral

Oral

Dosage form :

Tablets

Doses :

5/10 mg

Short Description:

Evrolia is an anticancer medicine containing the active substance everolimus. Evrolia reduces the blood supply to the tumour and slows down the growth and spread of cancer cells.

Product Introduction

What Evrolia is and what it is used for?

Evrolia is an anticancer medicine containing the active substance Everolimus.

Everolimus reduces the blood supply to the tumour and slows down the growth and spread of cancer cells.

Evrolia is used to treat adult patients with:

  • Hormone receptor-positive advanced breast cancer in postmenopausal women, in whom other treatments (so called “non-steroidal aromatase inhibitors”) no longer keep the disease under control. It is given together with a medicine called exemestane, a steroidal aromatase inhibitor, which is used for hormonal anticancer therapy.
  • Advanced tumours called neuroendocrine tumours that originate from the stomach, bowels, lung or pancreas. It is given if the tumours are inoperable and do not overproduce specific hormones or other related natural substances.
  • Advanced kidney cancer (advanced renal cell carcinoma), where other treatments

(so-called “VEGF-targeted therapy”) have not helped stop your disease.

Sunitinib

Chemical

Chemical

Oral

Oral

Zoledronic Acid

Chemical

Chemical

Injectable

Injectable